Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
Extending potential impact of innovative therapies in earlier lines of treatment, including TALZENNA ® plus XTANDI ® in metastatic castration-sensitive prostate cancer and TUKYSA ® as first-line maintenance for HER2-positive breast cancer New and updated data from next-generation pipeline of novel mechanisms and differentiated combinations across solid tumors, including sigvotatug vedotin, PF-08634404 and atirmociclib NEW YORK, April 21, 2026 BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) will present new data across its diverse, industry-leading Oncology pipeline and portfolio at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 29 – June 2, 2026, in Chicago. Data from more than 40 company-sponsored, investigator-sponsored and collaborative research abstracts, including three late-breaking sessions and eight oral and rapid oral presentations, will be shared. These data highlight Pfizer's leadership in establishing potential new standards of care across multiple canc
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026Business Wire
- CICC Initiates Coverage of Pfizer Inc. (PFE) With an Outperform Rating [Yahoo! Finance]Yahoo! Finance
- Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says [Yahoo! Finance]Yahoo! Finance
- After her cancer misdiagnosis, Lucy Liu advocates for early screening [USA TODAY]USA TODAY
PFE
Earnings
- 2/3/26 - Beat
PFE
Sec Filings
- 4/17/26 - Form 4
- 4/16/26 - Form 4
- 4/10/26 - Form 3
- PFE's page on the SEC website